Trial NCT01471964

View at ClinicalTrials.gov 
Org. Study IDs: OER-TH-036
Secondary IDs: NCI-2011-03306

Last trial update was posted on 2018-05-17

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer Metastatic Non-small Cell Lung Cancer Recurrent

Stopping Reasons

Phase I portion completed. Phase II will open pending amendment approval.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID